Invacare Co. (IVC) Receives $16.33 Average Target Price from Analysts
Shares of Invacare Co. (NYSE:IVC) have received a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $16.33.
A number of equities analysts recently weighed in on the stock. ValuEngine upgraded shares of Invacare from a “sell” rating to a “hold” rating in a research report on Monday, February 4th. Needham & Company LLC assumed coverage on shares of Invacare in a research report on Thursday, January 24th. They issued a “buy” rating and a $15.00 price objective on the stock. Finally, Zacks Investment Research upgraded shares of Invacare from a “hold” rating to a “strong-buy” rating and set a $11.00 price objective on the stock in a research report on Thursday, February 21st.
NYSE:IVC opened at $10.05 on Friday. Invacare has a 1-year low of $3.05 and a 1-year high of $20.00. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.36 and a current ratio of 2.01. The firm has a market capitalization of $333.66 million, a P/E ratio of -7.61 and a beta of 2.38.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 18th. Shareholders of record on Thursday, April 4th will be given a dividend of $0.0125 per share. The ex-dividend date of this dividend is Wednesday, April 3rd. This represents a $0.05 annualized dividend and a dividend yield of 0.50%. Invacare’s payout ratio is currently -3.79%.
Hedge funds and other institutional investors have recently modified their holdings of the business. Marshall Wace LLP purchased a new stake in shares of Invacare during the 3rd quarter worth $1,256,000. Trexquant Investment LP purchased a new stake in shares of Invacare during the 3rd quarter worth $148,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Invacare during the 3rd quarter worth $187,000. AQR Capital Management LLC purchased a new stake in shares of Invacare during the 3rd quarter worth $177,000. Finally, Royce & Associates LP boosted its position in shares of Invacare by 27.9% during the 4th quarter. Royce & Associates LP now owns 2,224,931 shares of the health services provider’s stock worth $9,567,000 after purchasing an additional 485,898 shares in the last quarter.
Invacare Company Profile
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific.
Featured Article: Diversification
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.